Back to News
Market Impact: 0.2
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellectis S.A.
Source: prnewswire.com
Legal & LitigationHealthcare & Biotech
Pomerantz LLP is investigating potential claims on behalf of investors in Cellectis S.A. (NASDAQ: CLLS). The release provides no allegations, financial figures, or details regarding the basis or scope of the investigation, but the inquiry represents a modest legal and reputational overhang for the biotech company.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.25
Ticker Sentiment
CLLS-0.45
More News
- Can Trump Oust Powell From the Fed Board? What to Know
- Nvidia Faces Questions Over China AI Chip Smuggling Cases
- New Mexico wants Meta to pay up to $40 billion in penalties after data privacy trial
- Paramount promised 30 movies a year to win Warner Bros. Losing Miramax if it fails may not scare it
- One of our most recent defensive buys cleared a hurdle and its stock jumped
- Manchester City Accused of ‘Sham’ Contracts, Facing Possible Relegation